Is it the end of the road for Ardelyx Inc?
Ardelyx, Inc. (NASDAQ: ARDX) lead candidate Tenapanor, is a targeted, first-in-class, oral, small molecule intended for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. The drug has the potential to become a foundational therapy for hyperphosphatemia and enable...
